Form 13-F position report

INVIVO THERAPEUTICS HOLDINGS C

Reported by BLAIR WILLIAM & CO IL

NVIV CUSIP 46186M209 Manager CIK 0000902367

Reported 0 shares, down 58,800 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q3 2017
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 2 Through Q3 2017

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value

Quarterly position history

How this manager's reported quarter-end position changed over time.

0 quarters
Quarterly reported position history for INVIVO THERAPEUTICS HOLDINGS C held by BLAIR WILLIAM & CO IL.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
This position's reported history falls outside the five-year preview window. A free account unlocks it. Unlock full history

Who else reported the position

51 managers reported INVIVO THERAPEUTICS HOLDINGS C for Q3 2017.

Managers reporting INVIVO THERAPEUTICS HOLDINGS C in Q3 2017.
Manager Activity Shares Change % of reported 13F Reported value Tenure
VANGUARD GROUP INC Reduced 813,992 -112,774 < 0.01% $1,201,000 10 qtrs
BlackRock Inc Reduced 576,241 -7,552 < 0.01% $835,000 10 qtrs
IMS Capital Management Added 495,809 +104,660 0.47% $731,000 10 qtrs
BAKER BROS ADVISORS LP Unchanged 400,000 0 < 0.01% $580,000 7 qtrs
MILLENNIUM MANAGEMENT LLC Reduced 376,951 -44,613 < 0.01% $547,000 6 qtrs
WELCH & FORBES LLC Reduced 347,659 -52,955 0.01% $504,000 10 qtrs
MORGAN STANLEY Reduced 235,212 -46,831 < 0.01% $341,000 10 qtrs
GEODE CAPITAL MANAGEMENT LLC Unchanged 179,802 0 < 0.01% $265,000 9 qtrs
BRIDGEWAY CAPITAL MANAGEMENT LLC Unchanged 145,650 0 < 0.01% $215,000 7 qtrs
RAYMOND JAMES & ASSOCIATES Added 86,833 +35,400 < 0.01% $126,000 7 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2017
Filed
November 13, 2017
Filing type
13F-HR
Position type
COM

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.